ESR1 and cancer: In a recent large study of PRS based on 375 autosomal AM variants, increasing AM was associated with lower risk of breast cancer, particularly estrogen receptor (ER) positive cancer, as well as ovarian cancer and endometrial cancer, which was independent of the effects of those variants on obesity[50].